Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuromyelitis Optica Spectrum Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT04131764
What this trial is testing

Diagnosis of ON With or Without MS or NMOSD

Who this might be right for
Multiple SclerosisNeuromyelitis Optica Spectrum Disorder AttackNeuromyelitis Optica Spectrum Disorder Relapse+2 more
Jagannadha R Avasarala 112
Post-approval studies (Phase 4)Looking for participantsNCT07410039
What this trial is testing

Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study

Who this might be right for
Neuromyelitis Optica Spectrum Disorder Attack
Chinese PLA General Hospital 200
Large-scale testing (Phase 3)Looking for participantsNCT07420296
What this trial is testing

Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorders (NMOSD)
Tianjin Medical University General Hospital 198
Early research (Phase 1)Study completedNCT02276963
What this trial is testing

Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum Disorder
Johns Hopkins University 6
Very early researchLooking for participantsNCT04561557
What this trial is testing

Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System

Who this might be right for
Autoimmune DiseasesAutoimmune Diseases of the Nervous SystemNeuromyelitis Optica Spectrum Disorder+7 more
Tongji Hospital 36
Post-approval studies (Phase 4)Looking for participantsNCT07010302
What this trial is testing

Rituximab Versus Ravulizumab, Inebilizumab, Satralizumab, and Eculizumab in NMOSD

Who this might be right for
NMOSD
Massachusetts General Hospital 540
Not applicableUnknownNCT04101058
What this trial is testing

Treatment Response Among Chinese Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis Optica Spectrum Disorders
Third Affiliated Hospital, Sun Yat-Sen University 200
Not applicableStudy completedNCT05871658
What this trial is testing

Efficacy of Electroacupuncture in NMOSD Patients With Pain: Study Protocol

Who this might be right for
Neuromyelitis Optica Spectrum DisordersPain
Yuanqi Zhao,MD 20
Not applicableLooking for participantsNCT05909761
What this trial is testing

Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy

Who this might be right for
Neuromyelitis Optica Spectrum DisorderPregnancy Related
Amgen 60
Not applicableUnknownNCT04822623
What this trial is testing

Imaging Evaluation of Central Nervous Autoimmune Diseases

Who this might be right for
MS (Multiple Sclerosis)NMO Spectrum Disorder
Qilu Hospital of Shandong University 300
Not applicableNot Yet RecruitingNCT07704294
What this trial is testing

Early Prediction of Outcomes Following Optic Neuritis: Development and Acceptability of a Prognostic Tool

Who this might be right for
Optic NeuritisMultiple SclerosisNeuromyelitis Optica Spectrum Disorder+2 more
King's College London 180
Not applicableNot Yet RecruitingNCT05415579
What this trial is testing

Demyelinating Diseases of the Central Nervous System Registry for Patients With Traditional Chinese Medicine (DATE-TCM)

Who this might be right for
Demyelinating Diseases of the Central Nervous System (DDC)
Dongzhimen Hospital, Beijing 2,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06561009
What this trial is testing

Safety and Efficacy of BAFFR CART for Relapsed/ Refractory Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Tianjin Medical University General Hospital 20
Large-scale testing (Phase 3)Looking for participantsNCT05349006
What this trial is testing

Azathioprine in MOGAD

Who this might be right for
Central Nervous System InflammationMOG-IgG Associated Disease
Hospices Civils de Lyon 126
Large-scale testing (Phase 3)Study completedNCT02003144
What this trial is testing

An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc. 119
Not applicableLooking for participantsNCT04106830
What this trial is testing

Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)

Who this might be right for
NMO Spectrum DisorderMRIMultiple Sclerosis+1 more
Beijing Tiantan Hospital 1,000
Not applicableStudy completedNCT04355611
What this trial is testing

Epidemiological Characteristics of COVID-19 in Patients With MS or NMO

Who this might be right for
Multiple SclerosisNMO Spectrum DisorderCOVID-19
Assistance Publique - Hôpitaux de Paris 2,465
Not applicableUnknownNCT05414487
What this trial is testing

Effects of Ofatumumab Treatment on Immune Cells and Meningeal Lymphatic Drainage in Patients With Demyelinating Diseases

Who this might be right for
Multiple SclerosisNeuromyelitis Optica Spectrum DisorderDemyelinating Diseases of the Central Nervous System
Tianjin Medical University General Hospital 34
Not applicableLooking for participantsNCT06941584
What this trial is testing

Analysis of the Role of AIRE in Autoimmune Neurological Diseases Associated With Autoantibodies

Who this might be right for
AIRE Deficiency
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 40
Testing effectiveness (Phase 2)UnknownNCT01364246
What this trial is testing

Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Progressive Multiple Sclerosis and Neuromyelitis Optica

Who this might be right for
Progressive Multiple SclerosisNeuromyelitis Optica.
Shenzhen Beike Bio-Technology Co., Ltd. 20
Next Page